• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在胎盘植入谱系疾病患者的胎盘、脐带和母血清中表达的沉默调节蛋白 1。

Expression of sirtuins 1 in placenta, umbilical cord, and maternal serum of patients diagnosed with placenta accreta spectrum.

机构信息

Inonu University, Faculty of Science and Art, Department of Molecular Biology and Genetics - Malatya, Turkey.

Dicle University, Department of Obstetrics and Gynecology -Diyarbakır, Turkey.

出版信息

Rev Assoc Med Bras (1992). 2024 Aug 16;70(8):e20240314. doi: 10.1590/1806-9282.20240314. eCollection 2024.

DOI:10.1590/1806-9282.20240314
PMID:39166679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11329260/
Abstract

OBJECTIVE

Placenta accreta spectrum (PAS) is defined as the attachment of the placenta to the uterine wall in varying degrees. However, the studies have explored that the underlying molecular mechanisms of the PAS are very limited. Sirtuins 1 (SIRT1) is associated with placental development by controlling trophoblast cell invasion and remodeling of spiral arteries. We aimed to determine the expression level of SIRT1 in placentas, and maternal and umbilical cord serum of patients with PAS.

METHODS

In total, 30 individuals in control, 20 patients in the placenta previa group, and 30 patients in the PAS group were included in this study. The expression levels of SIRT1 in the placentas were determined by Western blot and immunohistochemistry. Serum levels of SIRT1 in maternal and umbilical cord blood were determined by ELISA.

RESULTS

SIRT1 was significantly lower in placentas of the PAS. However, maternal and umbilical cord serum samples were not significantly different between groups.

CONCLUSION

SIRT1 may play an important role in the pathogenesis of the PAS.

摘要

目的

胎盘部位过度增生谱(PAS)定义为胎盘在不同程度上附着于子宫壁。然而,已有研究表明,PAS 的潜在分子机制非常有限。Sirtuins 1(SIRT1)通过控制滋养细胞侵袭和螺旋动脉重塑与胎盘发育有关。我们旨在确定 SIRT1 在胎盘、患有 PAS 的产妇和脐血血清中的表达水平。

方法

本研究共纳入 30 名对照组、20 名前置胎盘组和 30 名 PAS 组患者。通过 Western blot 和免疫组织化学法测定胎盘组织中 SIRT1 的表达水平。通过 ELISA 法测定产妇和脐血血清中 SIRT1 的水平。

结果

PAS 患者的胎盘组织中 SIRT1 明显降低。然而,各组产妇和脐血血清样本之间无显著差异。

结论

SIRT1 可能在 PAS 的发病机制中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a4/11329260/13a39fd84781/1806-9282-ramb-70-08-e20240314-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a4/11329260/d1a747c6dac8/1806-9282-ramb-70-08-e20240314-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a4/11329260/13a39fd84781/1806-9282-ramb-70-08-e20240314-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a4/11329260/d1a747c6dac8/1806-9282-ramb-70-08-e20240314-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a4/11329260/13a39fd84781/1806-9282-ramb-70-08-e20240314-gf02.jpg

相似文献

1
Expression of sirtuins 1 in placenta, umbilical cord, and maternal serum of patients diagnosed with placenta accreta spectrum.在胎盘植入谱系疾病患者的胎盘、脐带和母血清中表达的沉默调节蛋白 1。
Rev Assoc Med Bras (1992). 2024 Aug 16;70(8):e20240314. doi: 10.1590/1806-9282.20240314. eCollection 2024.
2
Elevated Expression of ADAMTS-12 in Maternal and Umbilical Cord Serum of Placenta Accreta Spectrum.ADAMTS-12 在胎盘植入谱中母血和脐血清中的高表达。
Fetal Pediatr Pathol. 2023 Aug;42(4):642-650. doi: 10.1080/15513815.2023.2197057. Epub 2023 Apr 11.
3
Expression of sirtuin 2 and 7 in placenta accreta spectrum.Sirtuin 2 和 7 在胎盘植入谱中的表达。
Rev Assoc Med Bras (1992). 2023 Aug 14;69(8):e20230360. doi: 10.1590/1806-9282.20230360. eCollection 2023.
4
Predictive value of vascular endothelial growth factor and placenta growth factor for placenta accreta spectrum.血管内皮生长因子和胎盘生长因子对胎盘植入谱系疾病的预测价值。
J Obstet Gynaecol. 2022 Jul;42(5):900-905. doi: 10.1080/01443615.2021.1955337. Epub 2021 Sep 24.
5
Decreased placental and maternal serum TRAIL-R2 levels are associated with placenta accreta.胎盘和母体血清中肿瘤坏死因子相关凋亡诱导配体受体2(TRAIL-R2)水平降低与胎盘植入有关。
Placenta. 2016 Mar;39:1-6. doi: 10.1016/j.placenta.2016.01.004. Epub 2016 Jan 6.
6
The correlation between serum levels and placental tissue expression of PLGF and sFLT-1 and the FIGO grading of the placenta accreta spectrum disorders.血清 PLGF 和 sFLT-1 水平与胎盘组织表达水平及其与胎盘部位滋养细胞疾病 FIGO 分级的相关性。
J Matern Fetal Neonatal Med. 2023 Dec;36(1):2183744. doi: 10.1080/14767058.2023.2183744.
7
Customizing EV-CATCHER to Purify Placental Extracellular Vesicles from Maternal Plasma to Detect Placental Pathologies.定制 EV-CATCHER 从母体血浆中纯化胎盘细胞外囊泡以检测胎盘病理。
Int J Mol Sci. 2024 May 7;25(10):5102. doi: 10.3390/ijms25105102.
8
Shedding of Syncytiotrophoblast-Derived Extracellular Vesicles Is Increased in Placenta Previa and Accreta Spectrum.蜕膜合体滋养细胞衍生的细胞外囊泡在前置胎盘和胎盘植入谱系中增加。
Reprod Sci. 2024 Jul;31(7):2043-2048. doi: 10.1007/s43032-024-01491-1. Epub 2024 Mar 7.
9
Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.前瞻性评估剖宫产术后子宫瘢痕对胎盘植入谱系疾病围产期诊断的影响。
Ultrasound Obstet Gynecol. 2022 Apr;59(4):474-482. doi: 10.1002/uog.23732. Epub 2022 Mar 8.
10
Rethinking Prenatal Screening for Anomalies of Placental and Umbilical Cord Implantation.重新思考胎盘和脐带植入异常的产前筛查。
Obstet Gynecol. 2020 Dec;136(6):1211-1216. doi: 10.1097/AOG.0000000000004175.

引用本文的文献

1
Sirtuins and Their Implications in the Physiopathology of Gestational Diabetes Mellitus.沉默调节蛋白及其在妊娠期糖尿病生理病理学中的意义。
Pharmaceuticals (Basel). 2025 Jan 1;18(1):41. doi: 10.3390/ph18010041.
2
Insights into Reproductive Immunology and Placental Pathology.生殖免疫学与胎盘病理学研究进展。
Int J Mol Sci. 2024 Nov 12;25(22):12135. doi: 10.3390/ijms252212135.

本文引用的文献

1
HSPA4 Is a Biomarker of Placenta Accreta and Enhances the Angiogenesis Ability of Vessel Endothelial Cells.HSPA4 是胎盘植入的生物标志物,可增强血管内皮细胞的血管生成能力。
Int J Mol Sci. 2022 May 19;23(10):5682. doi: 10.3390/ijms23105682.
2
SIRT1 attenuates neuroinflammation by deacetylating HSPA4 in a mouse model of Parkinson's disease.在帕金森病小鼠模型中,SIRT1通过使HSPA4去乙酰化来减轻神经炎症。
Biochim Biophys Acta Mol Basis Dis. 2022 May 1;1868(5):166365. doi: 10.1016/j.bbadis.2022.166365. Epub 2022 Feb 11.
3
Integration of transcriptome and proteome profiles in placenta accreta reveals trophoblast over-migration as the underlying pathogenesis.
胎盘植入中转录组和蛋白质组图谱的整合揭示了滋养层过度迁移是潜在的发病机制。
Clin Proteomics. 2021 Dec 29;18(1):31. doi: 10.1186/s12014-021-09336-8.
4
Advanced Maternal Age-associated SIRT1 Deficiency Compromises Trophoblast Epithelial-Mesenchymal Transition through an Increase in Vimentin Acetylation.高龄相关的 SIRT1 缺乏通过增加波形蛋白乙酰化来损害滋养层上皮-间充质转化。
Aging Cell. 2021 Oct;20(10):e13491. doi: 10.1111/acel.13491. Epub 2021 Oct 3.
5
Placenta Accreta Spectrum Disorder: Uterine Dehiscence, Not Placental Invasion.胎盘植入谱系疾病:子宫破裂,而非胎盘侵入。
Obstet Gynecol. 2020 May;135(5):1104-1111. doi: 10.1097/AOG.0000000000003793.
6
Placenta Accreta Spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study.胎盘植入谱系(PAS)疾病:埃及米尼亚一家三级转诊医院不同管理策略的发生率、风险因素和结局:一项前瞻性研究。
BMC Pregnancy Childbirth. 2019 Aug 27;19(1):313. doi: 10.1186/s12884-019-2466-5.
7
The role of Zeb1 in the pathogenesis of morbidly adherent placenta.Zeb1 在病态性黏附性胎盘发病机制中的作用。
Mol Med Rep. 2019 Sep;20(3):2812-2822. doi: 10.3892/mmr.2019.10490. Epub 2019 Jul 12.
8
SIRT1 negatively regulates invasive and angiogenic activities of the extravillous trophoblast.SIRT1 负向调节绒毛外滋养细胞的侵袭和血管生成活性。
Am J Reprod Immunol. 2019 Oct;82(4):e13167. doi: 10.1111/aji.13167. Epub 2019 Jul 28.
9
FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders.FIGO 分类用于胎盘部位滋养细胞肿瘤的临床诊断。
Int J Gynaecol Obstet. 2019 Jul;146(1):20-24. doi: 10.1002/ijgo.12761.
10
Placenta Accreta Spectrum.胎盘植入谱系疾病。
Am J Obstet Gynecol. 2018 Dec;219(6):B2-B16. doi: 10.1016/j.ajog.2018.09.042.